NTRR’s subsidiary Diamond Anvil Designs to release cutting-edge vaporizer pen next month

Neutra Corp. (OTCBB: NTRR), a provider of all-natural wellness solutions, announced today that its wholly owned subsidiary, Diamond Anvil Designs, is preparing to release its cutting-edge new vaporizer pen next month.

NTRR expects the new product to make a splash in the marketplace due to its groundbreaking versatility. The new product features a revised atomizer that can be adapted to deliver a variety of nutraceutical substances, including dry herbs, oils and waxes. As the U.S. cannabis market and ancillary industries continue their boom, NTRR is highly optimistic that the versatile vapor pen will receive an enthusiastic response from the marketplace.

"After consulting with a number of people in and around the industry this spring, we've developed and implemented much more efficient atomizers to achieve higher performance benchmarks," said NTRR CEO Sydney Jim. "We're looking forward to a successful product launch in just a matter of weeks."

After revising its initial prototype following extensive feedback from consumers and retailers at Cannabis Cup Denver in April, Diamond Anvil is preparing to roll out its new signature product in mid-July for nationwide distribution. NTRR acquired the company earlier this year in order to deliver a lightweight, portable, smoke-free delivery system that will stand out from competing products in the marketplace thanks to its customizable power levels, multi-substance vaporization capacity and best-in-class durability.

Plans call for the Diamond Anvil vapor pen to be made available online and at select retailers initially, with more outlets to follow.

Source:

Neutra Corp.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows cannabis as a genotoxic substance with cancer risks